focus -WSS

focus

author：entertainment 2025-09-06 01:58:19 - browse：8896

Priscilla Chan and Mark Zuckerberg on stage, virtually, at the 2023 STAT Summit. STAT

Mark Zuckerberg and Priscilla Chan sit atop a fortune that is currently valued at $113 billion, and they’ve promised to give almost all of it away. Their philanthropic funding group, the Chan Zuckerberg Initiative, is committed to investing in an array of fields, including science, education, housing insecurity, and expanding access to startup capital to entrepreneurs of color.

In 2015, when the self-described science nerds pledged 99 percent of their Facebook fortune to philanthropic causes over their lifetimes, they did not specify how they might spread their wealth. But at the STAT Summit on Wednesday, the couple went further in describing their goals, doubling down on science.

“The science piece is a huge, huge part of that,” Zuckerberg said when asked about his spending plans. “I would imagine that if the company continues doing well that we will have $50 billion or more over time to put into this kind of work, but we want that to compound and grow over time as we get more confidence in the model.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Hospitals are piloting generative AI tools as regulators play catch

WSS

Hospitals are piloting generative AI tools as regulators play catch

Microbiome research is starting to find links to chronic diseases

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Congress may force more Covid

Emergency workers more likely to restrain Black patients: study

As AI regulations shape up, health tech startups beg for clarity

leisure time

focus

focus

United colonoscopy coverage change 'may cost lives,' doctors say

EpiPen alternative approval delay highlights citizen petition issue

Affirmative action in medical school literally saved lives

Medicare Advantage enrollment hits roughly 33.4 million

Dobbs anniversary: the lost opportunity of abortion as health care

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

FDA approval of Sarepta Duchenne genetic therapy gives me hope

EpiPen alternative approval delay highlights citizen petition issue

Activists slam private health insurers over coverage restrictions

In 'major milestone,' FDA approves first cell therapy for solid tumors

entertainment

Opioid cravings were reduced by anti

Second xenotransplant done with gene

Intarcia’s device

MD Anderson's Padmanee Sharma responds to research credit suit

Thermo Fisher plant for manufacturing gene therapies to expand

FDA panel to weigh approval of NurOwn, controversial ALS drug

focus

explore

Wikipedia

knowledge